A continuing survey of drug-resistant tuberculosis, New York City, April 1994.

BACKGROUND A 1991 survey showed high levels of drug resistance among tuberculosis patients in New York, NY. As a result, the tuberculosis control program was strengthened, including expanded use of directly observed therapy and improved infection control. METHODS We collected isolates from every patient in New York City with a positive culture for Mycobacterium tuberculosis during April 1994; results were compared with those in the April 1991 survey. RESULTS From 1991 to 1994, the number of patients decreased from 466 to 332 patients. The percentage with isolates resistant to 1 or more antituberculosis drugs decreased from 33% to 24% (P < .01); with isolates resistant to at least isoniazid decreased from 26% to 18% (P < .05); and with isolates resistant to both isoniazid and rifampin decreased from 19% to 13% (P < .05). The number of patients with isolates resistant to both isoniazid and rifampin decreased by more than 50%. Among never previously treated patients, the percentage with resistance to 1 or more drugs decreased from 22% in 1991 to 13% in 1994 (P < .05). The number of patients with consistently positive culture results for more than 4 months decreased from 130 to 44. A history of antituberculosis treatment was the strongest predictor of drug resistance (odds ratio = 3.1; P < .001). Human immunodeficiency virus infection was associated with drug resistance among patients who never had been treated for tuberculosis. CONCLUSIONS Drug-resistant tuberculosis declined significantly in New York City from 1991 to 1994. Measures to control and prevent tuberculosis were associated with a 29% decrease in the proportion of drug resistance and a 52% decrease in the number of patients with multidrug-resistant tuberculosis.

[1]  J. Perriens.  Pulmonary tuberculosis in HIV-infected patients in Zaire , 1996 .

[2]  T. Frieden,et al.  Tuberculosis in New York City--turning the tide. , 1995, The New England journal of medicine.

[3]  I. Onorato,et al.  The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. , 1995, The New England journal of medicine.

[4]  P. Piot,et al.  Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. , 1995, The New England journal of medicine.

[5]  R. Cooper.  What Is Balance in the Physician Workforce?-Reply , 1995 .

[6]  D. Horn,et al.  Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing. , 1995, JAMA.

[7]  C. Beck-Sague,et al.  Control of nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis among healthcare workers and HIV-infected patients , 1995, The Lancet.

[8]  S. Maloney,et al.  Efficacy of Control Measures in Preventing Nosocomial Transmission of Multidrug-Resistant Tuberculosis to Patients and Health Care Workers , 1995, Annals of Internal Medicine.

[9]  R. Chaisson,et al.  Effectiveness of supervised, intermittent therapy for tuberculosis in HIV‐infected patients , 1994, AIDS.

[10]  D. Snider,et al.  Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention. , 1994, American journal of respiratory and critical care medicine.

[11]  S. Weis,et al.  The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. , 1994, The New England journal of medicine.

[12]  D. Snider,et al.  Nationwide survey of drug-resistant tuberculosis in the United States. , 1994, JAMA.

[13]  M. Diomande,et al.  The mortality and pathology of HIV infection in a West African city , 1993, AIDS.

[14]  W. Lew,et al.  The sixth Nationwide Tuberculosis Prevalence Survey in Korea, 1990. , 1993, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[15]  J. T. Crawford,et al.  Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. , 1993, The Journal of infectious diseases.

[16]  G. Schoolnik,et al.  Molecular strain typing of Mycobacterium tuberculosis to confirm cross-contamination in the mycobacteriology laboratory and modification of procedures to minimize occurrence of false-positive cultures , 1993, Journal of clinical microbiology.

[17]  T. Frieden,et al.  The emergence of drug-resistant tuberculosis in New York City. , 1993, The New England journal of medicine.

[18]  J. T. Crawford,et al.  Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology , 1993, Journal of clinical microbiology.

[19]  S. Kim,et al.  Drug resistance of Mycobacterium tuberculosis in Korea. , 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[20]  J. T. Crawford,et al.  An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. , 1992, The New England journal of medicine.

[21]  K. Brudney,et al.  Resurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs , 1991, The American review of respiratory disease.

[22]  D. Snider,et al.  Tuberculosis in patients with human immunodeficiency virus infection. , 1991, The New England journal of medicine.

[23]  R. M. Joshi,et al.  Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya. , 1989, Tropical and geographical medicine.

[24]  F. Malaguzzi Valeri,et al.  [Drug resistance of Mycobacterium tuberculosis]. , 1970, Giornale di pneumologia.